• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD4 T细胞能够排斥主要组织相容性复合体I类不相容的皮肤移植。

CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts.

作者信息

Wise M, Zelenika D, Bemelman F, Latinne D, Bazin H, Cobbold S, Waldmann H

机构信息

Sir William Dunn School of Pathology, Oxford, GB.

出版信息

Eur J Immunol. 1999 Jan;29(1):156-67. doi: 10.1002/(SICI)1521-4141(199901)29:01<156::AID-IMMU156>3.0.CO;2-K.

DOI:10.1002/(SICI)1521-4141(199901)29:01<156::AID-IMMU156>3.0.CO;2-K
PMID:9933097
Abstract

We have re-investigated the roles of CD4 and CD8 T cell subsets in skin graft rejection across a single class I MHC disparity. Recipient mice were transplanted with skin from donors transgenic for the class I MHC molecule Kb. As expected, CD8 T cells were sufficient for rapid injection; but surprisingly, CD4 T cells were also competent to do the same. Rejection was dependent on one or the other subset, since elimination of both resulted in indefinite graft survival. The possibility that alloantibody was the downstream effector of CD4 mediated rejection was excluded because CD8-depleted mice rendered B cell deficient still rejected rapidly, but T cell-depleted recipients with pre-existing high titers of alloantibody were unable to do so. In addition, if CD4 cells act to reject by recruiting and/or activating macrophages then this was not dependent on CR3, IFN-gamma or TNF-alpha. Transplantation of skin grafts where the MHC class I disparity was at the level of passenger leukocytes only, demonstrated that transient bystander damage could occur, but that this was insufficient to result in full rejection. We surmise that for CD4 T cells to reject an MHC class I-incompatible graft it is necessary that an appropriate allogeneic peptide is processed and presented in the context of recipient MHC class II. CD4 T cells from B6 mice may fail to reject skin from MHC class I mutants because of the lack of such MHC class II-restricted presentation.

摘要

我们重新研究了CD4和CD8 T细胞亚群在单一I类主要组织相容性复合体(MHC)差异的皮肤移植排斥反应中的作用。将来自I类MHC分子Kb转基因供体的皮肤移植到受体小鼠体内。正如预期的那样,CD8 T细胞足以引发快速排斥;但令人惊讶的是,CD4 T细胞也有同样的能力。排斥反应依赖于其中一个亚群,因为消除这两个亚群都会导致移植皮肤长期存活。由于去除CD8的小鼠即使B细胞缺陷仍能快速排斥,而预先存在高滴度同种抗体的T细胞缺陷受体则无法排斥,因此排除了同种抗体是CD4介导的排斥反应下游效应器的可能性。此外,如果CD4细胞通过招募和/或激活巨噬细胞来发挥排斥作用,那么这并不依赖于补体受体3(CR3)、γ干扰素(IFN-γ)或肿瘤坏死因子-α(TNF-α)。仅在过客白细胞水平存在I类MHC差异的皮肤移植实验表明,可能会发生短暂的旁观者损伤,但这不足以导致完全排斥。我们推测,CD4 T细胞要排斥I类MHC不相容的移植皮肤,必须有合适的同种异体肽在受体II类MHC的背景下进行加工和呈递。来自B6小鼠的CD4 T细胞可能无法排斥I类MHC突变体的皮肤,因为缺乏这种II类MHC限制性呈递。

相似文献

1
CD4 T cells can reject major histocompatibility complex class I-incompatible skin grafts.CD4 T细胞能够排斥主要组织相容性复合体I类不相容的皮肤移植。
Eur J Immunol. 1999 Jan;29(1):156-67. doi: 10.1002/(SICI)1521-4141(199901)29:01<156::AID-IMMU156>3.0.CO;2-K.
2
Rejection of grafts with no H-2 disparity in TAP1 mutant mice: CD4 T cells are important effector cells and self H-2b class I molecules are target.TAP1突变小鼠中无H-2差异的移植物排斥反应:CD4 T细胞是重要的效应细胞,自身H-2b I类分子是靶标。
Transpl Immunol. 2002 May;9(2-4):101-10. doi: 10.1016/s0966-3274(02)00032-1.
3
Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.在 CD8 细胞耗竭的 H-2(k) 受体中,FK506 对同种异体 K(b) - 皮肤移植物的特异性耐受诱导需要少量的 K(b) 抗原。
Transpl Immunol. 2005 Oct;15(1):9-16. doi: 10.1016/j.trim.2005.02.005.
4
Adoptively transferred CD4+ lymphocytes from CD8 -/- mice are sufficient to mediate the rejection of MHC class II or class I disparate skin grafts.从CD8 -/-小鼠过继转移的CD4+淋巴细胞足以介导对MHC II类或I类不相容皮肤移植物的排斥反应。
J Immunol. 1996 Jun 1;156(11):4114-9.
5
CD8+ effector cells responding to residual class I antigens, with help from CD4+ cells stimulated indirectly, cause rejection of "major histocompatibility complex-deficient" skin grafts.在间接刺激的CD4+细胞的帮助下,对残留的I类抗原作出反应的CD8+效应细胞会导致“主要组织相容性复合体缺陷”皮肤移植物的排斥反应。
Transplantation. 1997 Apr 27;63(8):1123-33. doi: 10.1097/00007890-199704270-00012.
6
Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo.体内CD8 + T细胞耗竭的小鼠中,跨越I类主要组织相容性屏障的皮肤同种异体移植排斥反应的细胞基础。
J Exp Med. 1991 Jun 1;173(6):1463-71. doi: 10.1084/jem.173.6.1463.
7
Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.源自同种异体I类主要组织相容性复合体抗原α螺旋的肽是心脏移植排斥后CD4+和CD8+T细胞及B细胞反应的有效诱导剂。
Transplantation. 1995 Feb 15;59(3):401-10.
8
CD4-negative cytotoxic T cells with a T cell receptor alpha/beta intermediate expression in CD8-deficient mice.在CD8缺陷小鼠中具有T细胞受体α/β中间表达的CD4阴性细胞毒性T细胞。
Eur J Immunol. 1996 Jan;26(1):213-8. doi: 10.1002/eji.1830260133.
9
Skin graft rejection elicited by beta 2-microglobulin as a minor transplantation antigen involves multiple effector pathways: role of Fas-Fas ligand interactions and Th2-dependent graft eosinophil infiltrates.由β2-微球蛋白作为次要移植抗原引发的皮肤移植排斥反应涉及多种效应途径:Fas-Fas配体相互作用和Th2依赖性移植嗜酸性粒细胞浸润的作用。
J Immunol. 2002 Jul 1;169(1):500-6. doi: 10.4049/jimmunol.169.1.500.
10
CD4+ T cell-mediated rejection of major histocompatibility complex class I-disparate grafts: a role for alloantibody.CD4 + T细胞介导的主要组织相容性复合体I类不相合移植物排斥反应:同种异体抗体的作用。
Eur J Immunol. 1993 Sep;23(9):2078-84. doi: 10.1002/eji.1830230906.

引用本文的文献

1
Extracellular matrix proteins regulate NK cell function in peripheral tissues.细胞外基质蛋白在外周组织中调节自然杀伤细胞的功能。
Sci Adv. 2022 Mar 18;8(11):eabk3327. doi: 10.1126/sciadv.abk3327. Epub 2022 Mar 16.
2
Genetics, pathogenesis and clinical interventions in type 1 diabetes.1 型糖尿病的遗传学、发病机制和临床干预。
Nature. 2010 Apr 29;464(7293):1293-300. doi: 10.1038/nature08933.
3
Induction of transplantation tolerance by combining non-myeloablative conditioning with delivery of alloantigen by T cells.通过将非清髓性预处理与T细胞递送同种异体抗原相结合来诱导移植耐受。
Clin Immunol. 2008 May;127(2):130-7. doi: 10.1016/j.clim.2008.01.005. Epub 2008 Feb 15.